Post-earnings recap
Reported
Mon, Mar 8, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Castle Biosciences reported a loss per share of $0.23, which was below expectations. The stock reacted negatively, declining by 4.20%. The lack of revenue data and management commentary leaves uncertainty about the company's performance and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.23 | N/A | -109.09% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.